Common Class of Cancer Drugs May Not Lead to Cognitive Decline

News   Apr 27, 2016

 
Common Class of Cancer Drugs May Not Lead to Cognitive Decline
 
 
 

RELATED ARTICLES

Computer Algorithms More Reliable than Standard Toxicology Tests on Animals

News

Advanced algorithms working from large chemical databases can predict a new chemical’s toxicity better than standard animal tests, suggests a study.

READ MORE

Lab Innovations 2018 – Registration Opens and Keynotes Announced

News

Learn and earn CPD points at the UK’s only lab-dedicated showcase and scientific seminar series.

READ MORE

Anti-TNF Drug Offers Hope to Patients with Disabling Hand Condition

News

Scientists have found that injection of the anti-TNF drug adalimumab into Dupuytren's disease nodules results in the reduction of the cell characteristics responsible for progression of Dupuytren's disease.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE
 

We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy